Skip to content

Clinical trials

Phase 3 Ovarian Neoplasms trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 3 Country / region: Netherlands Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20071
20093
20101
20111
20122
20132
20141
20151
20161
20183
20191
20202
20212
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting6
Terminated5
Recruiting4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
European Organisation for Research and Treatment of Cancer - EORTC3
Hoffmann-La Roche3
Pfizer2
Tesaro, Inc.2
The Netherlands Cancer Institute2
ARCAGY/ GINECO GROUP1
Amgen1
Boehringer Ingelheim1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms32
Fallopian Tube Neoplasms9
Carcinoma, Ovarian Epithelial5
Peritoneal Neoplasms2
Breast Neoplasms1
Endometrial Neoplasms1
Fibrosarcoma1
Hemangiosarcoma1
Histiocytoma, Malignant Fibrous1
Kidney Neoplasms1

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.